SOX10 and breast carcinoma: In terms of genomic drivers of SOX10 expression in breast cancer, copy-number (CN) amplification or gain at the SOX10 locus was evident in ~20% of TNBCs (Fig. 2b) and was associated with higher mRNA levels in both METABRIC and TCGA datasets (Fisher’s Exact p ≤ 0.001).